gabexate has been researched along with Gallstone Disease in 2 studies
Gabexate: A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shimoda, I | 2 |
| Ishizuka, H | 1 |
| Murakami, M | 1 |
| Sato, K | 2 |
| Hirano, H | 2 |
| Tanno, N | 2 |
| Ohira, C | 1 |
| Koizumi, M | 2 |
| Toyota, T | 2 |
| Ishizuka, J | 1 |
2 other studies available for gabexate and Gallstone Disease
| Article | Year |
|---|---|
[A new experimental trial for dissolution of gallbladder stones].
Topics: Animals; Cholelithiasis; Cholesterol; Cricetinae; Deoxycholic Acid; Drug Therapy, Combination; Ester | 1989 |
Combination therapy of trypsin inhibitor with ursodeoxycholic acid on cholesterol gallbladder stone.
Topics: Cholelithiasis; Cholesterol; Deoxycholic Acid; Drug Therapy, Combination; Esters; Gabexate; Guanidin | 1989 |